{"title":"Can Metronidazole Cause a Disulfiram-Like Reaction? A Case-Control Study Propensity Matched by Age, Sex, and Ethanol Concentration.","authors":"Ryan Feldman, Rachael Jaszczenski","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>There is controversy over the existence of a metronidazole-induced disulfiram-like reaction. Uncontrolled case reports suggest metronidazole can cause a severe disulfiram-like reaction in combination with ethanol. Criticism of these cases suggest the observed effects appear to be as likely caused by ethanol as by a drug interaction. Controlled experimental data refute these reports, demonstrating metronidazole does not increase acetaldehyde and cannot reliably produce disulfiram-like reactions. The purpose of this study is to retrospectively assess the incidence of clinical effects consistent with a disulfiram-like reaction in a population of patients with confirmed ethanol use who received metronidazole. As alcohol may also be responsible for the effects seen, the incidence of effects is assessed against a control group matched for age, sex, and ethanol concentration.</p><p><strong>Methods: </strong>A retrospective chart review was performed from December 1, 2010, through December 31, 2020 on emergency department patients with ethanol use confirmed via detectable ethanol concentration who received metronidazole while ethanol was predicted to still be present in the serum. A matched comparator group with the same ethanol concentrations, as well as sex and age, was generated for comparison. The incidence of disulfiram-like reaction symptoms documented in the medical record was compared between groups.</p><p><strong>Results: </strong>Thirty-six patients were included in the study: 18 in the metronidazole group and 18 in the ethanol concentration matched control group. The mean age in both groups was 46 years. The metronidazole group was 50% male, and the mean ethanol concentration was 0.21 g/dL. The control group was 44.4% male. There was significantly less hypertension in the metronidazole group compared to the control group (16.7% vs 61.1%, <i>P</i> $lt; 0.0001). There were no other significant difference in disulfiram-like effects between the two groups. No patients who received metronidazole and had a detectable ethanol concentration had a suspected disulfiram-like reaction documented in the medical record.</p><p><strong>Conclusions: </strong>This data set further supports the lack of a disulfiram-like reaction when metronidazole is used in patients with recent ethanol use in the acute care setting. Additionally, it highlights that the clinical effects of a disulfiram-like reactions may be present at baseline from ethanol ingestion or underlying disease regardless of metronidazole use. These findings are consistent with well-controlled human and animal data demonstrating no increase in acetaldehyde concentrations or disulfiram-like symptoms when metronidazole is co-administered with ethanol. In patients where metronidazole is indicated as the superior agent, its use should not be avoided due to concern about an interaction with ethanol.</p>","PeriodicalId":38747,"journal":{"name":"Wisconsin Medical Journal","volume":"122 3","pages":"171-177"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wisconsin Medical Journal","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: There is controversy over the existence of a metronidazole-induced disulfiram-like reaction. Uncontrolled case reports suggest metronidazole can cause a severe disulfiram-like reaction in combination with ethanol. Criticism of these cases suggest the observed effects appear to be as likely caused by ethanol as by a drug interaction. Controlled experimental data refute these reports, demonstrating metronidazole does not increase acetaldehyde and cannot reliably produce disulfiram-like reactions. The purpose of this study is to retrospectively assess the incidence of clinical effects consistent with a disulfiram-like reaction in a population of patients with confirmed ethanol use who received metronidazole. As alcohol may also be responsible for the effects seen, the incidence of effects is assessed against a control group matched for age, sex, and ethanol concentration.
Methods: A retrospective chart review was performed from December 1, 2010, through December 31, 2020 on emergency department patients with ethanol use confirmed via detectable ethanol concentration who received metronidazole while ethanol was predicted to still be present in the serum. A matched comparator group with the same ethanol concentrations, as well as sex and age, was generated for comparison. The incidence of disulfiram-like reaction symptoms documented in the medical record was compared between groups.
Results: Thirty-six patients were included in the study: 18 in the metronidazole group and 18 in the ethanol concentration matched control group. The mean age in both groups was 46 years. The metronidazole group was 50% male, and the mean ethanol concentration was 0.21 g/dL. The control group was 44.4% male. There was significantly less hypertension in the metronidazole group compared to the control group (16.7% vs 61.1%, P $lt; 0.0001). There were no other significant difference in disulfiram-like effects between the two groups. No patients who received metronidazole and had a detectable ethanol concentration had a suspected disulfiram-like reaction documented in the medical record.
Conclusions: This data set further supports the lack of a disulfiram-like reaction when metronidazole is used in patients with recent ethanol use in the acute care setting. Additionally, it highlights that the clinical effects of a disulfiram-like reactions may be present at baseline from ethanol ingestion or underlying disease regardless of metronidazole use. These findings are consistent with well-controlled human and animal data demonstrating no increase in acetaldehyde concentrations or disulfiram-like symptoms when metronidazole is co-administered with ethanol. In patients where metronidazole is indicated as the superior agent, its use should not be avoided due to concern about an interaction with ethanol.
简介:甲硝唑诱导的双硫仑样反应存在争议。不受控制的病例报告表明,甲硝唑与乙醇结合可引起严重的双硫仑样反应。对这些病例的批评表明,观察到的影响似乎是由乙醇引起的,也可能是由药物相互作用引起的。对照实验数据反驳了这些报告,证明甲硝唑不会增加乙醛,也不能可靠地产生双硫仑样反应。本研究的目的是回顾性评估在接受甲硝唑治疗的确认使用乙醇的患者群体中与双硫仑样反应一致的临床效应发生率。由于酒精也可能对所见的影响负责,因此对影响的发生率进行了评估,以对照年龄,性别和乙醇浓度相匹配的对照组。方法:对2010年12月1日至2020年12月31日期间接受甲硝唑治疗且预测血清中仍存在乙醇的急诊科乙醇使用患者进行回顾性图表回顾,这些患者通过检测乙醇浓度证实使用了乙醇。一个匹配的比较组,具有相同的乙醇浓度,以及性别和年龄,产生比较。比较医疗记录中记录的双硫仑样反应症状的发生率。结果:共纳入36例患者,甲硝唑组18例,乙醇浓度匹配对照组18例。两组患者的平均年龄均为46岁。甲硝唑组男性占50%,平均乙醇浓度0.21 g/dL。对照组男性占44.4%。甲硝唑组高血压发生率明显低于对照组(16.7% vs 61.1%, P $lt;0.0001)。两组之间在双硫仑样效应方面没有其他显著差异。接受甲硝唑治疗并检测到乙醇浓度的患者在医疗记录中没有出现疑似双硫仑样反应。结论:该数据集进一步支持急性护理环境中近期使用乙醇的患者使用甲硝唑时缺乏双硫仑样反应。此外,该研究强调,无论是否使用甲硝唑,双硫仑样反应的临床效应可能存在于乙醇摄入或潜在疾病的基线。这些发现与控制良好的人类和动物数据一致,表明当甲硝唑与乙醇共给药时,乙醛浓度或双硫仑样症状没有增加。在甲硝唑作为首选药物的患者中,不应由于担心与乙醇的相互作用而避免使用甲硝唑。
期刊介绍:
The Wisconsin Medical Society is the largest association of medical doctors in the state with more than 12,000 members dedicated to the best interests of their patients. With that in mind, wisconsinmedicalsociety.org offers patients a unique source for reliable, physician-reviewed medical information. The Wisconsin Medical Society has been a trusted source for health policy leadership since 1841.